Skip to main content
Fig. 4 | Cardiovascular Diabetology

Fig. 4

From: Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial

Fig. 4Fig. 4

Change from baseline in metabolic outcomes in those with (left panel) vs without (right panel) metabolic syndrome at baseline: a HbA1c, b SBP, c weight, d triglycerides, e HDL, f log(UACR), g waist circumference. Results from MMRM models as described in "Materials and methods" section. HbA1c glycated hemoglobin, HDL-C high-density lipoprotein, SBP systolic blood pressure, UACR urine albumin creatinine ratio

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840